Lyndra Therapeutics, Inc. is a biotechnology company that developed a weekly oral formulation of risperidone using its LYNX™ drug delivery platform, backed by the Gates Foundation and Gilead. It received a strategic investment from Sun Pharma in 2023 but ceased operations in early 2025 due to insufficient funding for its Phase 3 safety study.
Filed February 20, 2025 · Albany, NY
Your competitors in Albany are getting unlimited new business leads.
LYNDRA THERAPEUTICS, INC. is a biotechnology business (Corp) registered on February 20, 2025 with the New York Division of Corporations. The business is located in Albany, New York.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
LYNDRA THERAPEUTICS, INC. was registered as Corp on February 20, 2025 in New York.
LYNDRA THERAPEUTICS, INC.'s principal address on file is Albany, NY, 12260.
LYNDRA THERAPEUTICS, INC. is classified as a biotechnology business (drug delivery).
No EIN was found on file for LYNDRA THERAPEUTICS, INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.